Protagonist Therapeutics Inc (NASDAQ: PTGX) Loses -24.65% From High. Why That Could Change?
Currently, there are 61.93M common shares owned by the public and among those 58.31M shares have been available to trade. The company’s stock has a 5-day price change of 2.63% and 26.83% over the past three months. PTGX shares are trading 18.29% year to date (YTD), with the 12-month market performance up to 43.99% higher. […]
Growth Story Still Intact For Protagonist Therapeutics Inc (PTGX)
Protagonist Therapeutics Inc (PTGX) concluded trading on Thursday at a closing price of $28.52, with 4.61 million shares of worth about $131.35 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 53.58% during that period and on Thursday, February 01 price saw a gain […]